ARTELO BIOSCIENCES, INC. Increase (Decrease) in Prepaid Expense and Other Assets
ARTELO BIOSCIENCES, INC. (ARTL) reported Increase (Decrease) in Prepaid Expense and Other Assets of $79.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $25.00K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $54.00K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$18.00K, a 129.51% decline year-over-year.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$53.00K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$129.00K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$457.00K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$195.00K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in prepaid expense and other assets for fiscal 2021 was -$239.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 4 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $79.00K 10-Q · filed 2026-08-12 | $61.00K derived: sum of 3 quarters · filed 2026-08-12 | $8.00K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2026-03-31 | $54.00K 10-Q · filed 2026-05-14 | $36.00K derived: sum of 2 quarters · filed 2026-05-14 | -$17.00K derived: sum of 3 quarters · filed 2026-05-14 | -$66.00K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$71.00K derived: sum of 2 quarters · filed 2026-02-24 | -$120.00K derived: sum of 3 quarters · filed 2026-08-12 | -$129.00K 10-K · filed 2026-02-24 | |||
| 2025-09-30 | -$53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$102.00K derived: sum of 2 quarters · filed 2026-08-12 | -$111.00K 10-Q · filed 2025-11-12 | -$50.00K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | -$49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$58.00K 10-Q · filed 2026-08-12 | $3.00K derived: sum of 3 quarters · filed 2026-08-12 | -$475.00K derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | -$9.00K 10-Q · filed 2026-05-14 | $52.00K derived: sum of 2 quarters · filed 2026-05-14 | -$426.00K derived: sum of 3 quarters · filed 2026-05-14 | -$471.00K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$417.00K derived: sum of 2 quarters · filed 2026-02-24 | -$462.00K derived: sum of 3 quarters · filed 2026-02-24 | -$457.00K 10-K · filed 2026-02-24 | |||
| 2024-09-30 | -$478.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$523.00K derived: sum of 2 quarters · filed 2025-11-12 | -$518.00K 10-Q · filed 2025-11-12 | -$591.00K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$45.00K derived: 10-Q 6 month − 8-K 3 month · filed 2025-08-13 | -$40.00K 10-Q · filed 2025-08-13 | -$113.00K derived: sum of 3 quarters · filed 2025-08-13 | -$369.00K derived: sum of 4 quarters · filed 2025-08-13 | |||
| 2024-03-31 | $5.00K 8-K · filed 2025-07-11 | -$5.00K 10-Q · filed 2025-05-13 | -$68.00K derived: sum of 2 quarters · filed 2025-07-11 | -$324.00K derived: sum of 3 quarters · filed 2025-07-11 | |||
| 2023-12-31 | -$73.00K derived: 8-K 12 month − 10-Q 9 month · filed 2025-07-11 | -$329.00K derived: sum of 2 quarters · filed 2025-07-11 | -$430.00K 8-K · filed 2025-07-11 | $430.00K 10-K · filed 2024-03-25 | |||
| 2023-09-30 | -$256.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$357.00K 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | -$101.00K 10-Q · filed 2024-08-13 | ||||||
| 2022-12-31 | -$195.00K 10-K · filed 2024-03-25 | ||||||
| 2022-03-31 | $594.00K 10-Q · filed 2022-05-12 | ||||||
| 2021-12-31 | -$63.00K 10-KT · filed 2022-03-21 | ||||||
| 2021-11-30 | -$91.00K 10-Q · filed 2022-01-12 | -$305.69K derived: sum of 2 quarters · filed 2022-03-21 | -$319.55K derived: sum of 3 quarters · filed 2022-03-21 | ||||
| 2021-08-31 | -$214.69K derived: 10-KT 12 month − 10-Q 9 month · filed 2022-03-21 | -$228.55K derived: sum of 2 quarters · filed 2022-03-21 | -$239.00K 10-KT · filed 2022-03-21 | ||||
| 2021-05-31 | -$13.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-12 | -$24.31K 10-Q · filed 2021-07-12 | |||||
| 2021-03-31 | -$58.00K 10-Q · filed 2022-05-12 | ||||||
| 2021-02-28 | -$92.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | -$10.45K 10-Q · filed 2021-04-13 | -$237.47K derived: sum of 3 quarters · filed 2022-03-21 | -$291.29K derived: sum of 4 quarters · filed 2022-03-21 | |||
| 2020-12-31 | -$323.00K 10-KT · filed 2022-03-21 | ||||||
| 2020-11-30 | $82.00K 10-Q · filed 2022-01-12 | -$82.20K 10-Q · filed 2021-01-14 | -$145.03K derived: sum of 2 quarters · filed 2022-03-21 | -$198.84K derived: sum of 3 quarters · filed 2022-03-21 | -$203.60K derived: sum of 4 quarters · filed 2022-03-21 | ||
| 2020-08-31 | -$227.03K derived: 10-KT 12 month − 10-Q 9 month · filed 2022-03-21 | -$280.84K derived: sum of 2 quarters · filed 2022-03-21 | -$285.60K derived: sum of 3 quarters · filed 2022-03-21 | -$171.00K 10-KT · filed 2022-03-21 | |||
| 2020-05-31 | -$53.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-12 | -$58.57K derived: sum of 2 quarters · filed 2021-07-12 | $56.03K 10-Q · filed 2021-07-12 | ||||
| 2020-02-29 | -$4.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-13 | $109.84K 10-Q · filed 2021-04-13 | |||||
| 2019-11-30 | $114.60K 10-Q · filed 2021-01-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |